Mannitab Pharma Specialities Private Limited
About Mannitab Pharma Specialities Private Limited
Data last updated:
Mannitab Pharma Specialities Private Limited is a private limited company based in Malegaon, Maharashtra, India, a subsidiary of Corn Products Development Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC381884. Its GSTIN is 27AAPCM7308F1Z8 (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Rushabh Anilkumar Lodha and Suk Gu Kim.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lodha Bhuvan Post Box No. 31 Malegaon, Maharashtra, India – 423203.
As per the financials filed for FY 2025, the company reported a revenue of ₹123.03 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹42.49 Lakh (net margin 0.3%) and EBITDA of ₹35.37 Cr (EBITDA margin 28.7%).
The company has about 14 employees on its provident fund (EPFO) records.
The company has 1 deal on record (1 funding round), with disclosed funding of ₹181.17 Cr; the latest was in December 2022. Its 10 peer companies in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Quad Lifesciences Private Limited with revenue of ₹123.66 Cr. The company has 3 MSME Form 1 returns on record between 2023 and 2024, listing 19 overdue payments to 6 micro and small suppliers.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressLodha Bhuvan Post Box No. 31 Malegaon, Maharashtra, India – 423203
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mannitab Pharma Specialities Private Limited
The main business activity of Mannitab Pharma Specialities is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mannitab Pharma Specialities Private Limited FY 2025 filings available
Mannitab Pharma Specialities Private Limited reported revenue of ₹123.03 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mannitab Pharma Specialities Private Limited
Revenue rose 21% in the latest year. EBITDA rose 32% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Mannitab Pharma Specialities Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹35.37 Cr | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹42.49 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Mannitab Pharma Specialities Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 28.7% | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mannitab Pharma Specialities are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Quad Lifesciences Private Limited | ₹123.66 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Derabassi, Punjab, India |
| Jaya Speciality Chemicals Private Limited | ₹123.48 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Bhilai, Chhattisgarh, India |
| Harshvardhans Laboratories Private Limited | ₹123.35 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Dhar, Madhya Pradesh, India |
| Paramount Surgimed Limited | ₹123.26 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Rubicon Formulations Private Limited | ₹123.25 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Aurangabad, Maharashtra, India |
| Mannitab Pharma Specialities Private Limited this company | ₹123.03 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Malegaon, Maharashtra, India |
| Roopa Industries Limited Listed | ₹122.98 Cr (FY 2025) | •••• | •••• | 72.0% | •••• | Kurnool, A.P, Andhra Pradesh, India |
| Omkar Chemical Industries Private Limited | ₹122.88 Cr (FY 2025) | •••• | •••• | 779.0% | •••• | Anklesvar, Gujarat, India |
| Hwatsi Chemical Private Limited | ₹122.69 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Mumbai, Maharashtra, India |
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Valsad, Gujarat, India |
| Disposafe Health and Life Care Limited | ₹122.62 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Mannitab Pharma Specialities by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited is audited by S S MUTHA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S S MUTHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rushabh Anilkumar Lodha | Director | 02 May 2022 | 4 Years 5 Months | Current |
| Suk Gu Kim | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
| Dineshkumar Bhagchand Lodha Also directs: M B Sugars and Pharmaceuticals Private Limited | Director | 02 May 2022 | 4 Years 5 Months | Current |
| Harshad Naik Also directs: Spark Ingredients Private Limited | Additional Director | 30 Nov 2025 | 0 Years 10 Months | Current |
| Stephen Kane Latreille Also directs: Amishi Drugs and Chemicals Private Limited | Director | 26 Aug 2024 | 2 Years 1 Months | Current |
Ownership and Shareholding of Mannitab Pharma Specialities Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹181.17 Cr; the latest was in December 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Funding round | ₹181.17 Cr | Investors: Corn Products Development Inc |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 19 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Osheen Logistica Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Omkar Traders | •••• | •••• | •••• |
| Dhanashree Polymers Private Limited | •••• | •••• | •••• |
| Safexpress Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited has a workforce of 14 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities Private Limited has 17 board changes on record since 2022: 11 appointments and 6 cessations. The latest: Harshad Naik was appointed as Additional Director on 30 Nov 2025.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mannitab Pharma Specialities Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mannitab Pharma Specialities Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCM7308F1Z8 | Maharashtra | Active | 20 Jul 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mannitab Pharma Specialities Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mannitab Pharma Specialities Private Limited
Mannitab Pharma Specialities is an active private limited company based in Malegaon, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2022 (4+ years old) and is registered under CIN U24290MH2022PTC381884.
Mannitab Pharma Specialities reported revenue of ₹123.03 Cr for FY 2025 (up 21% YoY).
Mannitab Pharma Specialities has 5 current directors:
- Rushabh Anilkumar Lodha - Director
- Suk Gu Kim - Director
- Dineshkumar Bhagchand Lodha - Director
- Harshad Naik - Additional Director
- Stephen Kane Latreille - Director
Mannitab Pharma Specialities reported a net profit of ₹42.49 Lakh (net margin 0.3%) and EBITDA of ₹35.37 Cr (EBITDA margin 28.7%) for FY 2025, as per its filed financial statements.
The GSTIN of Mannitab Pharma Specialities is 27AAPCM7308F1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mannitab Pharma Specialities is U24290MH2022PTC381884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mannitab Pharma Specialities was incorporated on 02 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Mannitab Pharma Specialities has 1 deal on record (1 funding round), with disclosed funding of ₹181.17 Cr; the latest was in December 2022.
The peers of Mannitab Pharma Specialities by revenue are Quad Lifesciences Private Limited, Jaya Speciality Chemicals Private Limited, Harshvardhans Laboratories Private Limited, Paramount Surgimed Limited, Rubicon Formulations Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harshad Naik was appointed as Additional Director on 30 Nov 2025. Sriprakash Krishnan ceased to be Director on 30 Nov 2025. Stephen Kane Latreille was appointed as Director on 26 Aug 2024. Mannitab Pharma Specialities has 17 board changes on record in total.
Mannitab Pharma Specialities has 3 MSME Form 1 returns on record between 2023 and 2024, listing 19 overdue payments to 6 micro and small suppliers. The latest return was filed on 26 Apr 2024.
The registered office of Mannitab Pharma Specialities is at Lodha Bhuvan Post Box No. 31 Malegaon, Maharashtra, India – 423203.